MARKHAM, ON / ACCESS Newswire / March 4, 2026 / iFabric Corp. ("iFabric" or the "Company") (TSX:IFA)(OTCQX:IFABF) is pleased to announce that its wholly-owned subsidiary, Intelligent Fabric Technologies (North America) Inc. ("IFTNA"), has secured a 1,000store expansion of Doctor's Choice® scrubs at a leading U.S. national bigbox retailer. This expansion significantly broadens instore access to Doctor's Choice® scrubs following the program's initial rollout, which began online and progressed into stores duri ...

Core Insights - MoneyShow is a pioneer in investor education since 1981, focusing on financial media and investment conferences [1] - The company organizes leading investment and trading conferences that attract thousands of investors for workshops and seminars [1] - MoneyShow also provides exclusive seminars-at-sea in collaboration with top partners in the investment industry [1] - The company operates an award-winning online community, Moneyshow.com, and publishes free newsletters that offer ongoing investment and trading ideas [1]

Company Overview - Bimergen Energy Corporation is a U.S.-based independent power producer specializing in the development, ownership, and operation of standalone battery energy storage systems (BESS) [5] - The company focuses on utility-scale and distributed storage projects aimed at providing grid reliability, renewable integration, and flexible energy solutions [5] - Bimergen manages the full project lifecycle, including site selection, permitting, engineering, procurement, construction, and operations, with a portfolio spanning multiple power markets across the United States [5] Recent Highlights - Bimergen Energy has recently uplisted on NYSE American and raised $13.6 million through a concurrent offering [7] - The company announced the formal approval of its Redbird project, a 100 MW / 400 MWh battery energy storage system in Texas, under its Joint Development Agreement (JDA) [7] - Bimergen completed the acquisition of approximately 80 MW of late-stage distributed generation battery energy storage projects in ERCOT South from Aggreko and executed simultaneous financing [7] - The company holds a robust portfolio of 23 BESS projects totaling 2 GW across key U.S. power regions [7] - Bimergen announced $250 million in strategic capital commitments for project financings [7] Revenue Model - The company has established long-term contracts with financial partners to guarantee minimum revenues with upside revenue-sharing [7] - Bimergen operates a sustainable and scalable revenue model with primarily a two-fold revenue stream: Project Development Fees upon project acceptances from financing partners and Commercial Revenues from energy arbitrage during project operations [7] - Monetization partners have been established for federal Investment Tax Credits (ITC) of up to 50% of capital expenditures upon the commencement of commercial operations [7] Market Position - Bimergen Energy enjoys favorable market tailwinds and sustainability due to rapidly increasing demand driven by AI proliferation and data centers [7]

WEST PALM BEACH, Fla.--(BUSINESS WIRE)--Chatham Completes Substantial Acquisition, Increases Dividend 11 Percent. ...

Core Viewpoint - WeRide Inc. will release its unaudited financial results for Q4 and full year 2025 on March 23, 2026, before U.S. market opens [1] Group 1: Financial Results Announcement - The earnings conference call is scheduled for 8:00 A.M. U.S. Eastern Time on March 23, 2026, with registration required for participants [2] - A live and archived webcast of the conference call will be available on the Company's investor relations website [3] Group 2: Company Overview - WeRide is a global leader in the autonomous driving industry and the first publicly traded robotaxi company, with operations in over 30 cities across 11 countries [4] - The Company has received autonomous driving permits in eight markets, including China, Switzerland, and the US, and offers products and services from L2 to L4 [4] - WeRide was recognized in Fortune's 2025 Change the World and 2025 Future 50 lists [4]

Company Overview - Rubicon Associates is led by a Chartered Financial Analyst with over 20 years of experience in investment management, focusing on fixed income and preferred stock portfolios, as well as asset allocation and macro portfolios [1] - The principal has managed nearly $7 billion in credit investments and oversaw research and trading activities in the credit market, including a $20 billion short-duration fund [1] Investment Strategy - The company has experience analyzing and investing in both public and private companies globally, advising institutional clients on fixed income strategies, manager selection, and asset allocation [1] - Rubicon Associates has contributed written content to platforms such as Seeking Alpha, Learn Bonds, and TheStreet.com, in addition to providing advisory services to institutional and private investors [1]

BEA International Bank, a newly established French subsidiary of Banque Extérieure d'Algérie (BEA), has implemented Temenos Core Banking and Financial Crime Mitigation (FCM) software as a service (SaaS). The cloud-based deployment aims to provide BEA International Bank with a scalable platform to enhance its banking services in the French market, supporting the company's long-term growth objectives. The bank will offer services such as current and savings accounts, mortgage financing, and support for local ...

Core Insights - Enery has secured €460 million ($534 million) in syndicated green project financing to construct the Ogrezeni hybrid energy facility in Romania, which will integrate photovoltaic generation with battery energy storage [1][2] Financing Details - The financing will support a facility with an installed capacity of 761 MW-peak/534 MW-alternating current and over one gigawatt-hour of battery storage, aiming to provide renewable electricity for nearly 684,000 households annually and reduce carbon dioxide emissions by approximately 303,000 tons per year [1][2] - The funding agreement includes various financial instruments such as a revolving facility, term loan facilities, VAT and ancillary facilities, and an accordion feature valued at up to €79 million for potential expansion of battery storage capacity [2] Banking Consortium - A consortium of seven banking groups participated in the financing, with UniCredit acting as global and sustainability coordinator and bookrunner, while Intesa Sanpaolo Group and ING Bank also served as mandated lead arrangers [3] Sustainable Financing Framework - Enery structured the transaction under its Sustainable Financing Framework, which aligns with international green bond and loan principles, as well as EU Taxonomy Regulation [4] - Sustainable Fitch provided a second-party opinion confirming the framework's compliance with these standards [4] Company Statements - Enery's COO and CEO emphasized that securing this financing is a significant milestone in the company's growth and reflects confidence in its ability to deliver renewable energy infrastructure at scale [5] - The Sustainable Financing Framework is seen as a foundation for long-term development in Central and Eastern Europe, facilitating the transition to a low-carbon energy system [5] Legal and Advisory Support - Schönherr advised Enery on legal matters, while Clifford Chance Badea provided legal counsel to the lending banks [6] - The project is part of Enery's collaboration with the Three Seas Initiative Investment Fund, which focuses on infrastructure investments in energy, transport, and digital projects across Central and Eastern Europe [6]

Core Viewpoint - S&W has appointed James Wright as a partner in its business tax practice in Birmingham, enhancing its capabilities in advising on tax issues for UK and cross-border businesses [1][3]. Group 1: Appointment and Experience - James Wright brings extensive experience in corporate structuring, international taxation, transactional support, and ongoing compliance [1]. - Throughout his career, Wright has focused on helping businesses navigate significant tax challenges and respond to shifting tax rules and regulatory demands [2][3]. Group 2: Company Growth and Culture - Wright expressed enthusiasm about joining S&W, highlighting the firm's growth, ambition, and collaborative culture as key factors in his decision [2]. - Mark Webb, head of S&W Business Tax, emphasized that Wright's technical expertise and experience with complex clients will strengthen the firm's support for businesses in the UK and internationally [3]. Group 3: Recent Developments - S&W has also recently appointed Alexandra Bray as a partner in its business tax team in Bristol, indicating a broader investment in the senior team across its offices [4].

Core Insights - Esperion Therapeutics has signed a definitive agreement to acquire Corstasis Therapeutics to enhance its cardiovascular portfolio with the addition of Enbumyst, a bumetanide nasal spray approved by the FDA for treating oedema related to congestive heart failure, hepatic, and renal diseases in adults [1][3] Group 1: Acquisition Details - The acquisition involves Esperion purchasing all outstanding stock of Corstasis for an upfront cash payment of $75 million [1] - Corstasis shareholders may receive up to $180 million in additional payments based on regulatory and commercial milestones, along with low double-digit royalties on sales of Enbumyst and any follow-on products [2] - The transaction is expected to conclude in the second quarter of 2026 [2] Group 2: Product Information - Enbumyst is the first FDA-approved nasal spray diuretic, providing a self-administered outpatient option that may bridge the gap between oral and intravenous diuretic therapies for adults with oedema associated with liver disease, kidney disease, or heart failure [3] - Esperion plans to fund the acquisition through its current credit facilities and by monetizing its Japanese royalties via funds managed by Athyrium Capital Management and HealthCare Royalty [3] Group 3: Strategic Vision - Esperion's president and CEO, Sheldon Koenig, stated that this acquisition aligns with the company's long-term Vision 2040 and aims to bring meaningful innovation to patients struggling with diuretic therapy [4] - The integration of Enbumyst into Esperion's commercial platform is expected to drive sustained double-digit growth and strengthen the company's leadership in cardiovascular care [5] - In January 2024, Daiichi Sankyo Europe amended its existing collaboration with Esperion, valued at $125 million, further supporting the company's strategic initiatives [5]